[Other] Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3 |
|
This post will be closed automatically in 2026-10-12 17:55
Reward10points
|
10
A group sequential response-adaptive randomized double-blinded clinical trial to evaluate the safety and efficacy of add-on olanzapine plus pregabalin for the prevention of chemotherapy-induced nausea and vomiting.
20
A Novel MG 2D Animation Design Method under the Perspective of Convergence Media Using Intelligent Design Technology
20
Development of a Digital Inline Holography Technique to Characterize Airborne Supercooled Water Droplets and Ice Crystals for Aircraft Icing Studies
20
Local symmetry and mode-selective electron-phonon coupling of oxygen-related defects in AlN
20
Effects of Data Visualization Choices on Psychophysiological Responses, Judgment, and Audit Quality
